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Viperin Is Induced following Dengue Virus Type-2 (DENV-2)
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Abstract
The host protein viperin is an interferon stimulated gene (ISG) that is up-regulated during a number of viral infections. In
this study we have shown that dengue virus type-2 (DENV-2) infection significantly induced viperin, co-incident with
production of viral RNA and via a mechanism requiring retinoic acid-inducible gene I (RIG-I). Viperin did not inhibit DENV-2
entry but DENV-2 RNA and infectious virus release was inhibited in viperin expressing cells. Conversely, DENV-2 replicated to
higher tires earlier in viperin shRNA expressing cells. The anti-DENV effect of viperin was mediated by residues within the C-
terminal 17 amino acids of viperin and did not require the N-terminal residues, including the helix domain, leucine zipper
and S-adenosylmethionine (SAM) motifs known to be involved in viperin intracellular membrane association. Viperin
showed co-localisation with lipid droplet markers, and was co-localised and interacted with DENV-2 capsid (CA), NS3 and
viral RNA. The ability of viperin to interact with DENV-2 NS3 was associated with its anti-viral activity, while co-localisation of
viperin with lipid droplets was not. Thus, DENV-2 infection induces viperin which has anti-viral properties residing in the C-
terminal region of the protein that act to restrict early DENV-2 RNA production/accumulation, potentially via interaction of
viperin with DENV-2 NS3 and replication complexes. These anti-DENV-2 actions of viperin show both contrasts and
similarities with other described anti-viral mechanisms of viperin action and highlight the diverse nature of this unique anti-
viral host protein.
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Introduction
The interferon (IFN) response is triggered in cells infected by
RNA viruses, including members of the Flaviviridae family via a
number of RNA recognition pathways that ultimately act to limit
viral replication [1,2]. Production of type I interferons (IFNs; IFN-
a and IFN-b) by virus infected cells results in up-regulation of anti-
viral IFN-stimulated genes (ISGs) and cytokines [3]. Infection of
cells with the flavivirus, dengue virus (DENV) is recognised by the
toll-like receptor-3 (TLR3), retinoic acid inducible gene–I (RIG-I)
and melanoma differentiation associated gene-5 (MDA5) pathways
to induce the IFN response [4,5]. Microarray studies have shown
up-regulation of ISGs, including viperin during DENV infection in
cell lines and patient peripheral blood mononuclear cells (PBMC)
[6], as well as during DENV infection of macaques in both
macrophages and B-cells [7]. We and others have demonstrated
that viperin is induced by infection with a number of diverse
viruses as well as able to limit viral infection in most instances,
including the first reported up-regulation of viperin in human
cytomegalovirus (HCMV) infected cells [8,9,10]. Subsequently,
viperin has been shown to have anti-viral actions in other viral
infections such as hepatitis C virus (HCV), influenza virus, human
immunodeficiency virus (HIV), sindbis virus (SINV), the flaviviruses
Japanese encephalitis virus (JEV) and West Nile virus (WNV)
[9,10,11,12,13,14,15] and more recently, Bunyamwera virus [16]
and Chikungunya virus [17]. The roles and actions of viperin in
these different viral infections appear diverse and multifaceted
with anti-viral activity in some cases dependent on alterations to
lipid rafts (influenza, [14]), membrane localisation (HCV, [9]), the
radical S-adenosylmethionine (SAM) enzymatic activity of viperin
(HIV, [10]), negated by viral proteins (JEV, [11]) and even an
enhancing role under some conditions for HCMV [18]. Viperin
also has anti-viral activity against DENV infection [6,13] however
the interaction of DENV and viperin has not been thoroughly
investigated.
In this study we have further defined the induction of viperin
and its mechanisms of anti-viral actions in DENV-2-infected cells,
using an infectious DENV-2 in vitro replication model and
including primary monocyte-derived macrophages (MDM) which
represent a target cell type for DENV in vivo. Results show that
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DENV-2 infection induces viperin mRNA and protein, that
expression of viperin is anti-viral, requiring the C-terminal but not
N-terminal regions of viperin protein, and restricts DENV-2
infection by reducing viral RNA production. Viperin co-localised
and interacted with DENV-2 CA, viral RNA and NS3 proteins.
The interaction of viperin and NS3 but not membrane association,
however, is necessary for viperins anti-viral actions. These results
show both similarities and differences to our recent data suggesting
that the anti-viral actions of viperin relate to its interaction with
HCV NS5A and VAP-A in HCV replication complexes [9] and
supports the growing evidence for both conserved and unique
mechanisms of action of viperin against viral infections, even
within the closely related Flaviviridae family of viruses.
Materials and Methods
Cells and virus stocks
Vero African green monkey kidney cells, A549, a human lung
carcinoma cell line, Huh-7 and Huh-7.5 human hepatoma cells
and primary monocyte-derived macrophages (MDM) were used
for DENV-2 infection studies and maintained as previously
described. Primary MDM were generated by adherence from
PBMC that were isolated from voluntary blood donation at the
Australian Red Cross Blood Service. Blood was provided
anonymously and used with approval from the Southern
Adelaide Clinical Human Research Ethics Committee. Infections
utilised DENV-2, Mon601, a derivative of the New Guinea C
strain [19] that was produced from in vitro transcribed RNA,
transfected into BHK-21, baby hamster kidney cells, amplified in
C6/36 insect cells and titred in Vero cells. Viperin shRNA and
control cells were generated in Huh-7 cells, as previously
described [9].
DENV-2 infection and quantitation
Cells were infected at a multiplicity of infection (MOI) of 0.1 or
1 for cell lines and an MOI of 3 for MDM for 90 min at 37uC, as
described previously [20,21,22]. At the indicated time points post
infection (pi) cell culture supernatants were collected, clarified by
centrifugation and stored at 280uC prior to performing a plaque
assay in Vero cells as previously described [21].
Western blot for viperin
MDM were generated and DENV-2 infected, as above and at
48 h pi cells lysed and lysates subjected to SDS-PAGE. Proteins
were transferred to nitrocellulose membranes and probed for
viperin (in house rabbit anti-viperin antibody, 1/1000 [12]) with
detection of complexes with goat-anti-rabbit-HRP conjugate and
chemiluminesence. Protein loading was normalised by re-probing
filters for b-actin (anti-rabbit b-actin, 1/500, BioVision). Images
were captured with a LAS-4000 imaging system (Fuji Corp) and
quantitated using Carestream Molecular Imaging Software 5.02
(Carestream Health Inc).
Plasmids and transfections
Wild type (WT) viperin and viperin mutant constructs were as
described previously [9]. The DENV-2 NS3-GFP and pEPI–GFP
CA constructs were a kind gift from Professor David Jans (Monash
University, Australia). Viperin mCherry fusion proteins were
created utilising pLenti6-mCherry; WT and viperin mutants were
cloned in frame (XhoI/SacII) into the construct using previously
described primers [9]. Cell lines were transfected using FuGene6
(Roche, IN) as per manufacturer’s instructions. The viperin coding
region was cloned into the lentiviral vector pLenti6/V5-D-TOPO
(Invitrogen, CA) and the control lentiviral plasmid pLenti6/V5-D-
TOPO-tdTomato was obtained from Dr Yuka Harata-Lee
(University of Adelaide, Adelaide). Infectious lentivirus was
generated as previously described [23]. Primary MDM were
transduced with tdTomato control or viperin expressing lentivirus
for 90 min at 37uC and were DENV-2 challenged at 24 h post
transduction.
RNA extraction and RT-PCR
Total cellular RNA was isolated from cells using Trizol
(Invitrogen), DNase treated and quantitated by spectrophotome-
try. For DENV-2 strand specific RT-PCR, 100 ng of denatured
RNA was reverse transcribed at 37uC for 1 h with 20 pmol of
DENV-2 specific primer (DENV5.1 or DENV3.2 [21]) attached
to a 19mer long sequence (Tag) [24] and 10 U MMuLV RT
(Promega, WI). The tagged DENV-2 cDNA was then subjected to
real time PCR using SYBER Green PCR mix (Applied
Biosystems, CA) and 20 pmole of each primer, Tag, DENV3.2
for negative (2ve strand) and DENV5.1 for positive (+ve strand),
as previously described [21]. Real time PCR for viperin and the
control gene RPLPO was performed as previously described on
the ABI 7000 prism [12]. Primer sequences for IFIT1 were 59
AACTTAATGCAGGAAGAACATGACAA and 59 CTGCCA-
GTCTGCCCATGTG.
Immunolabelling and co-localisation studies
Cells were cultured on gelatin coated glass coverslips, and fixed
in either 1% (v/v) formaldehyde for MDM and HeLa, or
acetone:methanol (1:1) for Huh-7 cells and stored at 220uC.
Slides were washed in PBS, and the formaldehyde fixed cells
permeabilised with 0.05% (v/v) IGEPAL before blocking in 4%
(v/v) goat serum, 2% (v/v) human serum, 0.4% (w/v) bovine
serum albumin (BSA) in Hanks buffered salts solution (Gibco BRL,
NY). Cells were immunolabelled using mouse anti-DENV-2
(serotypes 1–4, Santa Cruz Biotechnology Inc, 1/100 dilution), a
rabbit anti-viperin, a mouse anti-FLAG (Sigma, MO) or a mouse
anti-DENV CA antibodies (a kind gift from Prof David Jans,
Monash University, Australia). Immunoreactivity was detected
with goat anti-mouse IgG-Alexa 488, a goat anti-rabbit IgG-Alexa
647 or a goat anti-mouse IgG-Alexa 555 secondary antibodies
(Molecular probes, CA). Nuclei were labelled with Hoechst 33342
Author Summary
Viperin is a virally induced host protein that has been
previously shown to have antiviral activity against a variety
of viruses. Here we have demonstrated that viperin is also
anti-viral against the medically significant arbovirus,
dengue virus. Viperin was able to inhibit dengue virus at
the level of viral replication, and cell lines unable to
produce normal levels of viperin grew the virus to higher
titres. These anti-dengue effects of viperin were mediated
by amino acid residues in its C-terminus, and did not
require structural domains of the N-terminal region as has
been previously shown by us and others for the related
virus, hepatitis C virus. Viperin was also demonstrated to
co-localise and interact with the dengue capsid protein on
the surface of lipid droplets, as well as with the NS3
protein and viral RNA. Viperin’s association with NS3 was
further demonstrated to be involved in its anti-dengue
activities. The anti-viral activities of viperin presented in
this manuscript show both similarities and contrasts with
other described anti-viral mechanisms for the protein and
highlight the diverse nature of this unique anti-viral host
protein.
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(Molecular Probes, CA). BODIPY 493/503 (Invitrogen) was
prepared as a stock solution of 1 mg/ml in ethanol. Fluorescence
was visualised by confocal laser scanning microscopy (Biorad
Radiance 2100 or Leica SP5 Spectral Confocal Microscope). For
some experiments, quantification of intensity of immunofluores-
cence labelling was performed using ImageJ software (National
Institutes of Health). The mean grayscale value was obtained for
each channel for all cells where the image plane passed through
the nucleus and excluding any cells at edge of the image and
clusters of overlapping cells. Thresholds for detection of DENV-2
immunoreactivity were set at a grayscale value of three standard
errors of the mean above the mean grayscale value measured in
mock infected cells.
Immunoprecipitation
293T cells were transfected with pLenti6/V5-D-TOPO-viperin
for 3 h then allowed to recover for 2 h prior to infection with
DENV-2 at an MOI= 3. At 24 h pi cells were lysed (10 mM Tris,
pH 7.5, 100 mM NaCl, 0.5% (v/v) Triton X-100+complete mini
protease inhibitors [Roche]), lysates clarified and incubated for
1 hr with rabbit anti-FLAG antibody. Complexes were recovered
with protein A-sepharose, washed six times (10 mM Tris, pH 7.5,
100 mM NaCl, 0.05% [v/v] Triton X-100+protease inhibitors)
and resuspended in water. Precipitates were analysed for proteins
by western blot and total DENV-2 RNA by RT-PCR with
DENV5.1 and DENV3.2 primers, as described above with the
exception that the reverse transcription step was non-primer
directed.
Fluorescence Energy Resonance Transfer (FRET) analysis
Acceptor photobleaching was carried out as previously
described in [9] with the use of GFP and mCherry tagged protein
constructs. Pre and post-bleaching images were aligned using
ImageJ and the difference in fluorescence (DIF) analysed in 5–10
regions of each cell where lipid droplets and/or cytoplasmic
stained structures were positive for both proteins. At least 10
different cells in each of at least two independent experiments were
analysed to ensure reproducibility. Negative slides were prepared
by imaging cells with only the donor molecule present and treated
in parallel photobleaching experiments.
Statistical analysis
Student t-tests were utilised to analyse the distributions of 2
normally distributed data sets and experiments were performed a
minimum of three times, in triplicate or duplicate. Statistical
analysis was performed using SPSS 10.
Results
Viperin mRNA and protein is induced following DENV-2
infection
As mentioned previously, a number of viruses are able to induce
viperin expression, and to extend these observations we infected
cell lines and primary MDM with DENV-2. Cells were lysed at the
indicated time points pi, RNA extracted and analysed by RT-PCR
for viperin and DENV-2 negative strand (2ve) RNA, which is a
marker of productive DENV-2 replication. Viperin mRNA was
significantly induced in DENV-2 infected human cell lines with
approximately 25 fold induction in A549 lung carcinoma cells
(Figure 1A) and a lesser 4 fold increase in Huh-7 hepatoma cells
co-incident with high level DENV-2 2ve strand RNA production
(Figure 1B). In contrast viperin mRNA was not increased following
DENV-2 infection of Huh-7.5 cells, a cell line which is defective in
dsRNA signalling via a mutation in the pathogen-recognition
receptor RIG-I [25] (Figure 1C). Up-regulation of viperin by
DENV-2 infection was also demonstrated in primary MDM, with
a much greater, approximately 1000 fold induction of viperin
mRNA at 24 h pi (Figure 1D).
We next assessed up-regulation of viperin protein in MDM
since these showed the most significant change in viperin mRNA.
Cells were DENV-2 infected, lysed and analysed for viperin by
western blot with IFN-a treated cells used as a positive control.
Results show increased levels of viperin protein in DENV-2
infected primary MDM, at levels greater than that induced by IFN
alone (Figure 2A). We further characterised viperin protein in
DENV-2-MDM by confocal microscopy. As can be seen in
Figure 2B, at 24 h pi viperin was elevated in DENV-2 infected
compared with mock infected MDM. Interestingly MDM positive
for DENV antigen displayed reduced amounts of viperin protein,
whereas DENV-antigen negative bystander cells (indicated via
arrows, Figure 2B, upper panel) were shown to express signifi-
cantly increased levels of viperin. The intensity of viperin staining
in these different populations was quantitated. Results support the
visual up-regulation of viperin in DENV-2 compared to mock
infected cells, but most predominantly in the antigen negative,
bystander cells of the DENV-2 infected population (Figure 2C).
Viperin is anti-viral against DENV-2 infection in vitro
Ectopic expression of viperin has been previously shown to
inhibit DENV infection using virus and reporter virus-like particles
in vitro [6,13], however neither the anti-viral mechanism(s) or the
interaction with viperin has been fully explored. Here we first
transfected HeLa cells with plasmid to express WT viperin and at
24 h post transfection infected with DENV-2. Cells were fixed
24 h pi and immunolabelled for dsRNA and viperin. Results are
suggestive of anti-DENV activity of viperin, with individual cells
expressing viperin harbouring either no or very little DENV-2
RNA (Figure 3A). We next quantitated this potential anti-DENV-
2 activity of viperin using a panel of viperin mutants that have
previously been used to investigate viperins anti-HCV activity [9].
Although little is known about the structure/function relationship
of viperins anti-viral activity, recent work by us and others has
demonstrated that both the localisation of viperin to the ER
membrane through its N-terminal amphipathic helix, as well as its
C-terminal residues are essential for its ability to limit the
replication of HCV [9,26]. Transient expression of WT viperin
in Huh-7 cells significantly inhibited DENV-2 2ve strand RNA
levels by up to 61% (Figure 3B). A significant reduction of DENV-
2 2ve strand RNA was also observed for cells transfected with
viperin mutants in the SAM (SAM 1-3) domain, leucine zipper
(LZ) and N-terminal deletions from 17 and up to 50 amino acid
residues, suggesting that these regions play no role in the anti-viral
activity of viperin (Figure 3B). In contrast, C-terminal deletions, as
small as 17 amino acids, completely abolished the anti-DENV-2
activity of viperin (Figure 3B). These C-terminal deletion mutants
have previously been shown in our laboratory to retain the same
expression level and localisation as WT viperin [9]. Mutation of
the single C-terminal residue of viperin (CTM) partly abrogated
the anti-DENV-2 activity of WT viperin, although compared with
the no viperin control the CTM still produced a significant
reduction in DENV-2 2ve strand RNA levels (Figure 3B). These
results highlight the importance of the C-terminal end of viperin
for anti-viral activity and the C-terminal, 39D17 mutant is used as
a control in subsequent experiments.
Huh-7 or A549 cells were transfected to transiently express WT
or the C-terminal 39D17 mutant viperin lacking anti-viral activity,
infected with DENV-2 and were analysed at 24 h pi (Figure 3C
and D respectively). Results confirmed a significant reduction in
Viperin Is Anti-viral against DENV Infection
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both infectious virus release as determined by plaque assay of
media from infected cells and production of 2ve strand RNA
induced by WT but not 39D17 viperin expression in these two
different cell types.
Viperin is anti-viral against DENV-2 in primary human
cells
An important cell type for DENV infection in vivo are cells of the
monocyte-macrophage lineage. Additionally, these cells are major
contributors to the IFN response. As such we have analysed the
anti-viral actions of viperin in primary MDM. Given the difficulty
in transfecting MDM, we expressed viperin via lentivirus-mediated
transduction. MDM were transduced with a td-Tomato-red
fluorescent protein control or viperin encoding lentivirus expres-
sion vector, infected with DENV-2 and infection analysed. Results
show a significant reduction in infectious virus release from
lentivirus-viperin transduced MDM compared with lentivirus td-
Tomato transduced control MDM, with a significant 30 and 4 fold
decrease seen at 24 and 48 h pi respectively (the 8 h time point is
considered a measure of input virus and is not significantly
different between control and viperin transduced cells) (Figure 4A).
At 48 h pi cells were fixed and immunostained for viperin and
DENV-2 antigens, followed by confocal microscopy. Enumeration
of .600 cells from 10 different fields and two different infections
showed a significant reduction in the number of DENV-2 antigen
+ve cells in viperin compared with tdTomato transduced cells
(images not shown, 5.9%60.8 vs 9.5%60.6, p,0.05, Students
unpaired t-test). Additionally, we observed dramatically higher
levels of viperin protein in the DENV-2 infected cells compared
with mock-infected viperin-lentivirus transduced cells (Figure 4B).
Further, this up-regulation of viperin was again only observed in
the DENV-2 antigen 2ve bystander cells of this population
(Figure 4B). This likely represents up-regulation of endogenous
viperin, as demonstrated previously in DENV-2 infected MDM
(Figure 2B).
Knockdown of viperin in vitro increases DENV-2
replication
We next assessed the requirement for induction of viperin to
restrict DENV-2 replication using a well characterised viperin
shRNA Huh-7 cell line. Cells were DENV-2-infected at a lower
MOI (0.1) to avoid DENV-induction of viperin mRNA, as in
Figure 1. Viperin mRNA is induced in DENV-2 infected cells. Cells were infected with DENV-2 (MOI = 1 or MOI = 3 for MDM) and at various
time points pi intracellular RNA was extracted and viperin mRNA and DENV2ve strand RNA quantitated by real time RT-PCR. Results were normalised
against control RPLPO mRNA levels and expressed as fold change. Values represent average6 SEM (n= 3). (A) A549; (B) Huh-7; (C) Huh-7.5; (D) MDM.
* Significantly different in comparison to 0 h time point, p,0.05.
doi:10.1371/journal.pntd.0002178.g001
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Figure 2. Viperin protein is induced in DENV-2 infected cells. A. Primary MDM were left uninfected, treated with 500 U/ml IFN-a or DENV-2
infected. At 48 h pi cells were lysed and viperin protein analysed by western blot. Blots were re-probed for b-actin and images visualised by
chemiluminesence. Images were quantitated using Carestream Molecular Imaging Software and viperin signal normalised against b-actin. B. Primary
MDM were DENV-2 (i) or mock (ii) infected and at 24 h pi were fixed and immunostained for viperin and DENV, with detection of stained complexes
with anti-rabbit 647 (red) and anti-mouse 488 (green), respectively. Nuclei were stained with Hoechst (blue) and images collected by confocal
microscopy. C. Immunolabeling for viperin was quantitated in cells from mock-infected MDM and compared with antigen negative bystander and
DENV-2 antigen positive cells of the DENV-2 infected MDM cultures. Values represent average 6 SEM. (n = 111 mock; 27 DENV-antigen positive; 136
DENV-antigen negative bystander cells). * = significantly different, p,0.05, Students unpaired t-test. Results of a single experiment are shown which
was replicated.
doi:10.1371/journal.pntd.0002178.g002
Viperin Is Anti-viral against DENV Infection
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Figure 1, potentially overwhelming the capacity of the viperin
shRNA. DENV-2 infection of viperin shRNA cells resulted in a
significant, approximately 2 fold enhancement of infectious
DENV-2 release at 24 h pi compared with control shRNA
expressing cells (Figure 5A). By 48 h pi, infectious virus release
was comparable between viperin shRNA and control shRNA
expressing cells, possibly due to enhanced cytopathic effects in
viperin shRNA cells associated with the earlier and higher level of
DENV-2 replication, although this was not specifically quanti-
tated. DENV-2-infection did not induce viperin mRNA in viperin
shRNA expressing cells at 24 h pi (Figure 5B), although
expression was detected at 48 h pi in some instances. In all
cases, the unrelated ISG, IFIT1 mRNA, utilised as a control, was
induced to comparable levels in both DENV-2-infected viperin
shRNA and control shRNA expressing cells, demonstrating
effective induction of other anti-viral responses in the absence
of viperin (Figure 5C).
Viperin reduces early viral RNA production but not viral
entry
The lower levels of DENV-2 2ve strand RNA and viral release
observed in HeLa, Huh-7 cells and primary MDM following
infection of viperin expressing cells could be consistent with
restriction of DENV-2 entry. To investigate this possibility Huh-7
and A549 cells were transfected to express viperin and following
DENV-2 infection cells were immediately lysed and +ve strand
DENV-2 RNA, indicative of intracellular genomic input RNA,
quantitated by RT-PCR. Results showed no difference in
intracellular levels of +ve strand DENV-2 RNA between cells
transfected to express viperin and the inactive viperin C-terminal
mutant, 39D17 (Figure 6A). Additionally, DENV-2-infections were
performed as above and cells lysed at 6 h pi and 2ve strand
DENV-2 RNA quantitated. Results demonstrated a significant
reduction in the intracellular level of DENV-2 2ve strand RNA at
this early time point in both A549 and Huh-7 cells transfected with
Figure 3. Viperin is anti-viral against DENV-2 and requires C-terminal regions of the protein. (A) HeLa cells were transfected with either a
viperin-FLAG expression plasmid (i) or a control vector (ii) and at 24 h post transfection infected with DENV-2 (MOI = 1). At 24 h pi cells were fixed
and immunolabelled with anti-FLAG (viperin) and anti-dsRNA antibodies with detection of stained complexes with anti-rabbit 647 (red) and anti-
mouse 488 (green), respectively. Nuclei were stained with Hoechst (blue) and images collected by confocal microscopy. (B) Huh-7 cells were
transfected to express WT viperin or viperin mutants and at 24 h post transfection infected with DENV-2 (MOI = 0.1). 24 h pi RNA was extracted and
DENV-2 2ve strand PCR quantitated by real-time RT-PCR. Results were normalised against control RPLPO mRNA levels and expressed as fold change.
Values represent average6 SEM (n= 3). * = significantly different to no viperin control, ** = significantly different to no viperin control and WT viperin,
p,0.05, Students t-test. Similar experiments to (B) were performed in (C) Huh-7 or (D) A549. Cells were transfected using WT viperin or a 39D17
viperin expression construct and infected as in (B). Supernatant was sampled and analysed for infectious virus release by plaque assay and RNA
extracted from infected cells and DENV2ve strand RNA quantitated by real time RT-PCR. Results were normalised against control RPLPO mRNA levels
and expressed as fold change relative to 39D17 viperin control. Values represent average 6 SEM (n= 3). * = significantly different to WT viperin,
p,0.05, Students unpaired t-test.
doi:10.1371/journal.pntd.0002178.g003
Viperin Is Anti-viral against DENV Infection
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viperin (Figure 6B), demonstrating a post-entry restriction in early
DENV-2 RNA replication.
Our prior studies with HCV and viperin have demonstrated a
requirement for the anti-viral actions of viperin mediated through
lipid droplet and replication complex localisation and association
with NS5A [9]. We next assessed the ability of viperin to associate
with DENV-2 replication complexes by immunoprecipitation (IP).
293-T cells were transfected to express FLAG-tagged viperin,
infected with DENV-2 then at 24 h pi cells lysed and IPed with
anti-FLAG antibody. Precipitates were analysed for the presence
of total DENV-2 RNA by RT-PCR. Results demonstrate
successful co-precipitation of DENV-2 RNA with FLAG-antibody
(Figure 6C). Concurrent analysis of precipitates by western blot,
however failed to detect co-precipitated DENV-2 NS3 protein
(data not shown).
Viperin co-localises with both DENV-2 CA and NS3
The above data suggests the association of viperin with
complexes containing DENV RNA (ie. replication complexes).
Such complexes reportedly are also associated with cellular
membrane structures and DENV-2 NS3 protein [27,28]. The
maintenance, however of the anti-DENV-2 activity of viperin
containing N-terminal deletion mutants suggests that the ability of
viperin to associate with membranes is not required for its
restriction of DENV-2 infection (Figure 3A). We thus assessed the
cellular localisation of viperin in DENV-2 infected cells. Viperin
Figure 4. Viperin is anti-viral in primary MDM. Primary MDM were generated from peripheral blood and transduced with lentiviral particles
expressing control td-Tomato or WT viperin. At 24 h post transduction, cells were infected with DENV-2 (MOI = 3). (A) Supernatant was sampled and
infectious virus release quantitated by plaque assay. Values represent average 6 SEM (n= 3). * p,0.001; (B) Viperin lenti-transduced MDM were
DENV-2 or mock infected and at 48 h pi cells were fixed and immunolabelled for viperin and DENV with detection of complexes with Alexa-647 (red)
and Alexa-488 (green), respectively. Nuclei were stained with Hoechst (blue) and images collected by confocal microscopy.
doi:10.1371/journal.pntd.0002178.g004
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Figure 5. Induction of viperin is needed to restrict early viral replication. Viperin shRNA or control shRNA expressing Huh7 cells were
infected with DENV-2 (MOI = 0.1). (A) Supernatant was sampled and infectious virus release quantitated by plaque assay. Values represent average 6
SEM (n= 3); At the indicated time point pi cells were lysed, RNA extracted and analysed by real time RT-PCR for (B) viperin mRNA; (C) IFIT1 mRNA.
Values represent average 6 SEM (n= 4). Results were normalised against control RPLPO mRNA levels and expressed as fold change relative to mock
infected cells. * = significant at p,0.05, Students unpaired t-test.
doi:10.1371/journal.pntd.0002178.g005
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primarily localises to lipid droplets in Huh-7 cells as we have
shown previously [9], and as can be seen in Figure 7A; this
distribution remains unaltered in DENV-2 infected Huh-7 cells.
The DENV capsid (CA) protein has also been demonstrated to
localise to lipid droplets [29,30] and consistent with these previous
reports we observed partial co-localisation between DENV-2 CA
Figure 6. Viperin inhibits early DENV-2 replication and associates with DENV-2 RNA. A549 or Huh-7 cells were transfected with WT and
39D17 viperin control and at 24 h post transfection infected with DENV-2 (MOI 0.1). (A) Immediately following infection cells were washed twice,
trypsinised, lysed and DENV-2 +ve strand RNA quantitated by real time RT-PCR; (B) At 6 h pi RNA was extracted from infected cells and DENV-2 2ve
strand RNA quantitated by real time RT-PCR; RT-PCR results were normalised against RPLPO mRNA levels. Values represent average 6 SEM (n= 3), *
p,0.05, Students unpaired t-test, (C) 293T cells were transfected with viperin-FLAG, IPed with FLAG antibody or no antibody control and precipitates
analysed for DENV-2 RNA by RT-PCR. Values represent average 6 SEM (n= 4), * p,0.05, Students unpaired t-test.
doi:10.1371/journal.pntd.0002178.g006
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and viperin at the interface of lipid droplet-like structures (white
arrows, Figure 7B). Interestingly, viperin and the CA protein
appear to coat the surface of the droplet at distinct loci, with small
overlapping areas of co-localisation. Huh-7 cells were also co-
transfected with a DENV-2 NS3-GFP expression plasmid and
viperin. A clear co-localisation between DENV-2 NS3 and viperin
is observed at the surface of lipid droplet-like structures as well as
in distinct cytoplasmic loci (Figure 7C). The N-terminal viperin
deletion mutant (Vip59D33) which loses its ability to localise to
lipid droplets [9,31], but remains anti-viral against DENV-2
(Figure 3A), remained co-localised with DENV-2 NS3, although
the pattern of localisation was solely cytoplasmic (Figure 7C). This
observation demonstrates that viperin’s anti-viral activities may be
exerted through a possible interaction with NS3 but not
necessarily at the lipid droplet interface.
Viperin interacts with DENV-2 CA and NS3
As described above, although viperin co-precipitated DENV-2
RNA, IP experiments could not demonstrate co-precipitation of
NS3 with viperin from either DENV-2 infected or NS3/viperin
co-transfected cells (data not shown). These co-precipitation
experiments are likely confounded by our observation of low
levels of viperin protein in DENV-infected cells (Figure 2B) and
low levels of DENV-2 antigens in viperin transfected cells
(Figure 3A). Further, viperin is a lipid associated protein, which
are notoriously difficult to extract and retain physiological protein-
protein interactions.
We therefore investigated the physical interaction of viperin
with DENV-2 NS3 and CA by fluorescence energy resonance
transfer (FRET). Huh-7 cells were transfected with expression
plasmids for DENV-2 CA-GFP or DENV-2 NS3-GFP in
conjunction with either mCherry N-terminally tagged viperin-
WT, viperin 59D33 or viperin 39D17 and FRET acceptor
photobleaching performed. Results show positive FRET for
viperin-WT and the DENV-2 CA protein at the surface of the
lipid droplet (Figure 8A) demonstrating an interaction of WT-
viperin and CA proteins at this site. FRET analysis also
demonstrated an interaction of DENV-2 NS3 and WT-viperin
in distinct cytoplasmic foci (Figure 8B), similar to that seen in the
confocal co-localisation studies of these two proteins (Figure 7C).
No positive FRET was detected between DENV-2 NS3 and
viperin surrounding lipid droplet like structures, despite our prior
observation of co-localisation at these sites (Figure 7C). The
ampipathic helix mutant (59D33) of viperin, which retains its anti-
DENV-2 activity, but has lost its membrane localisation ability,
demonstrated a positive interaction by FRET analysis with
DENV-2 NS3, once again at distinct cytoplasmic foci within the
cells (Figure 8C). In contrast, the C-terminal viperin mutant,
39D17, which has no anti-DENV-2 activity but maintains WT
viperin localisation [9], showed no positive FRET with DENV-2
NS3 suggesting this protein is unable to interact with DENV-2
NS3. These results indicate that the C terminus of viperin
mediates its anti-DENV-2 activity through an interaction with
DENV-2 NS3 but does not require lipid droplet or membrane
association.
Discussion
Viperin is emerging as an important virus-induced ISG that can
be up-regulated by both IFN-dependent and independent
pathways and has a diverse array of anti-viral actions. Viperin
can be induced in an IFN independent manner via IFN regulatory
factor-1 (IRF-1), following infection with the RNA virus, vesicular
stomatis virus (VSV) [32]. In contrast, SINV induction of viperin
requires IFN but JEV induction of viperin occurs in an IFN-
independent manner that requires IRF-3 and AP-1 [11]. In this
study we show that viperin is induced early in DENV-2 infection
and similar to our observation in HCV infected cells, does not
occur in Huh-7.5 cells that are deficient in RIG-I [9]. IRF-3 and
AP-1 are transcription factors downstream of RIG-I activation
suggesting that the RIG-I pathway has an important role in
induction of viperin, at least for the Flaviviridae members JEV,
HCV and DENV. Furthermore, our studies in DENV-2-infected
viperin shRNA cells suggest that the viperin already present or
induced intracellularly in the DENV-2 infected cell acts to restrict
or control DENV-2 infection in this initial target cell. Additionally
our results from DENV-2-infected MDM show strong induction of
viperin protein in DENV antigen negative bystander cells. This
indicates that induction of viperin in these bystander cells,
probably secondary to the release of IFN from the DENV-2
infected cell, is likely to also be important for restricting DENV-2
spread. Our observation of a far greater level of induction of
viperin following DENV-2 infection compared with IFN stimula-
tion of primary MDM suggests that induction of viperin by
DENV-2, either in the initial DENV-2 infected cell or the
uninfected bystander cell, occurs via factors other than IFN that
are yet to be defined.
Viperin protein contains N-terminal ampipathic helical do-
mains that direct viperin cellular localisation to the endoplasmic
reticulum (ER) and lipid droplets [9,31,33]. The C-terminal
portion of viperin is relatively unstructured and highly conserved
amongst species; however its current function remains unknown.
Previously we have demonstrated that the anti-viral actions of
viperin are dependent on a number of functional domains of the
viperin protein (i) the N-terminus for intracellular ER and lipid
droplet localisation of viperin, (ii) the extreme C-terminus in the
context of HCV replication [9], and (iii) the radical SAM domain
in the context of HIV egress [10]. Using DENV-1 virus-like
particles (VLP) and a luciferase reporter replicon system, a
previous study has shown that viperin is induced by DENV-1
infection, inhibits DENV-1 RNA production and requires the N-
terminal SAM1 domain of viperin [13]. This same study showed a
similar induction of viperin, inhibition of RNA production and
requirement for the viperin SAM1 domain and in part, residues
within the first 50 amino acids of viperin during WNV infection.
In contrast, our study observed anti-DENV-2 activity of viperin
SAM1-4 mutants at levels comparable to WT viperin. The
differences in the requirement for the viperin SAM1 domain seen
in our current study compared with previous results with DENV-1
and WNV may be due to (i) the level of expression of viperin
through use of a tet-induction system compared with the transient
viperin transfection system in the current study; (ii) the analysis of
different markers of infection with viperin SAM1 reducing
infectious DENV-1 release [13] but in our study not DENV-2
2ve strand RNA; and/or (iii) the use of DENV-1 compared to
DENV-2 herein. Regardless, studies clearly suggest that the anti-
viral actions of viperin can be mediated by residues outside of the
SAM1 domain, including the N-terminal 50 amino acid residues
for WNV [13] and in our previous work with HCV, also the C-
terminal regions of viperin [9]. Consistent with this requirement of
the C-terminal region of viperin for anti-HCV activity, in our
current study we have similarly defined anti-DENV activity to
reside in the C-terminal 17 amino acids of viperin.
The specific regions of viperin necessary for anti-viral activity
between various viruses differs, as does the biological effect of
viperin during different virus infections. Viperin is reported to
inhibit release of influenza virus by disruption of lipid rafts [14], to
inhibit HIV egress [10] and to diminish viral protein production in
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HCMV infection [8]. In this study we show that viperin inhibits
early post-entry DENV-2 RNA replication consistent with prior
reported effects of viperin in inhibiting RNA replication in other
Flaviviridae family members, HCV [9] and WNV [13]. In
contrast, viperin is induced but is not anti-viral against the related
flavivirus, JEV due to mechanisms of JEV that proteolyse and
degrade viperin in infected cells [11]. However, contrary to earlier
reports of anti-viral activity of viperin against HCMV, a recent
study has shown that the vMIA protein of HCMV induces re-
localisation of viperin from the ER to mitochondria, resulting in an
increase in HCMV infection [18]. These contrasting effects of
viperin suggest that its effects on viral infection are multifaceted,
virus specific and involve multiple mechanisms of action including
alterations in the subcellular localisation of viperin.
Viperin has been shown to localise to lipid droplets and the ER.
Similarly we have shown here that viperin co-localises with the
lipid droplet marker, BODIPY, in DENV-2 infected cells and thus
the cellular localisation of viperin is unchanged during DENV-2
infection. The DENV CA localises to lipid droplets and preventing
this CA-lipid droplet association reduces DENV RNA replication
Figure 7. Viperin co-localises at lipid droplets and with DENV-2 CA and NS3. Huh-7 cells were transfected to express viperin-FLAG, DENV-2
infected (MOI 1) and at 24 h pi immunolabelled for viperin (anti-FLAG) and DENV, and examined via confocal microscopy for (A) viperin (red) using
Alexa555 and BODIPY (green); (B) viperin (red) using Alexa555 and DENV-2 CA (green) using Alexa488. (C) WT or 59D33 N-terminally FLAG tagged
viperin and DENV-2 NS3-GFP (green) were transfected into Huh-7 cells and immunolabelled for viperin with detection of complexes with Alexa-555
(red).
doi:10.1371/journal.pntd.0002178.g007
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Figure 8. Viperin interacts with DENV-2 CA and NS3 protein. Huh-7 cells were co-transfected with a DENV-2 CA-GFP and viperin-mCherry
expression vector (A), or DENV-2 NS3-GFP and expression plasmids for either viperin-mCherry (B), viperin 59D33-mCherry (C) or viperin 39D17-
mCherry (D). Slides were analysed on a Zeiss Axioplan microscope and FRET determined by acceptor photobleaching. DIF was calculated from
comparison of aligned pre and post-bleach images, from 5–10 regions per cell of at least 10 cells from 2 different experiments. Data are represented
as average 6 SEM with a significance of p,0.05 for (A), (B) and (C).
doi:10.1371/journal.pntd.0002178.g008
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and infectious virus particle production [30]. While we confirm
that viperin is able to co-localise and interact with the DENV-2
CA at lipid droplet-like structures (Figure 7B, 8B), our observation
that viperin N-terminal mutants, which lose the ability to localise
to lipid droplets, still retain substantial anti-DENV-2 activity
suggests that viperin has significant anti-DENV-2 activities
independent of its lipid droplet/CA association. We also
demonstrate that viperin co-localises and interacts with the
DENV-2-NS3 protein and co-precipitates with DENV-2 RNA,
both of which are components of DENV replication complexes
[27,28]. The interaction of viperin and DENV-2 NS3 was
independent of the N-terminal ampipathic helix, but reliant on
the C-terminus of viperin. Further, the ability of viperin to co-
localise and interact with DENV-2 NS3 correlated with anti-viral
activity. We propose that viperin has anti-viral activity mediated
by a C-terminus interaction with DENV-2 NS3 that reduces early
RNA production by interfering with DENV-2 replication com-
plexes. It remains to be determined whether this occurs solely
through a direct interaction with the DENV-2 NS3 protein, or
also through an intermediate pro-viral host cell factor, such as is
the case for HCV, whereby viperin interacts with both NS5A and
the pro-viral factor VAP-A [9,26]. Currently, the only known pro-
viral host factor for DENV that interacts with NS3 in the context
of functional replication complexes is fatty acid synthetase (FASN)
[34]. We feel FASN is an unlikely candidate as a target of viperin’s
actions since viperin and FASN exist in alternate cellular
compartments (Figure S1).
In conclusion, this study has revealed further critical functions of
viperin during DENV-2 replication and highlighted similarities
and differences in the mechanisms of induction and in the anti-
viral actions of viperin between DENV-2 and other medically
important Flaviviridae. This data highlights the incredibly diverse
anti-viral nature of viperin and the complexity of the viperin-virus
interaction.
Supporting Information
Figure S1 Viperin does not co-localise with FASN. Huh-7
cells were transiently transfected to express WT viperin-FLAG and
at 24 h post transfection were immunolabelled for viperin (red,
anti-FLAG) and FASN (green) with detection of complexes with
Alexa-555 and Alexa-488, respectively.
(TIF)
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